Title:
PHARMACEUTICAL COMPOSITION CONTAINING ZINC POLYPHOSPHATE
Document Type and Number:
WIPO Patent Application WO/2024/090538
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for the treatment or prevention of inflammatory bowel diseases, said pharmaceutical composition containing zinc polyphosphate as an active ingredient. The zinc polyphosphate in the present invention has intestinal-canal-barrier enhancing activity and can treat or prevent inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.
Inventors:
FUJIYA MIKIHIRO (JP)
KONISHI HIROAKI (JP)
OGAWA NAOKI (JP)
IKEDA KOHEI (JP)
ITO SAORI (JP)
MIYAHARA JUNICHI (JP)
KONISHI HIROAKI (JP)
OGAWA NAOKI (JP)
IKEDA KOHEI (JP)
ITO SAORI (JP)
MIYAHARA JUNICHI (JP)
Application Number:
PCT/JP2023/038804
Publication Date:
May 02, 2024
Filing Date:
October 27, 2023
Export Citation:
Assignee:
KAMUI PHARMA INC (JP)
NATIONAL UNIV CORPORATION ASAHIKAWA MEDICAL UNIV (JP)
KNC LABORATORIES CO LTD (JP)
NATIONAL UNIV CORPORATION ASAHIKAWA MEDICAL UNIV (JP)
KNC LABORATORIES CO LTD (JP)
International Classes:
A61K33/30; A61K33/42; A61P1/04; A61P29/00
Domestic Patent References:
| WO2016105431A1 | 2016-06-30 | |||
| WO2011125619A1 | 2011-10-13 | |||
| WO2021141066A1 | 2021-07-15 |
Foreign References:
| US20170348352A1 | 2017-12-07 |
Other References:
G PINETON DE CHAMBRUN: "Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice", MUCOSAL IMMUNOLOGY, NATURE PUBLISHING GROUP US, NEW YORK, vol. 7, no. 3, 1 May 2014 (2014-05-01), New York, pages 589 - 601, XP093164936, ISSN: 1933-0219, DOI: 10.1038/mi.2013.78
Attorney, Agent or Firm:
OHNO Seiji et al. (JP)
Download PDF: